Research progress of exosome lncRNA in liquid biopsy of colorectal cancer

doi:10.16352/j.issn.1001-6325.2023.02.317

Abstract

CLC Number:

R735.3

YAO Liuxu, LI Yuhong, JIANG Zongming. Research progress of exosome lncRNA in liquid biopsy of colorectal cancer[J]. Basic & Clinical Medicine, 2023, 43(2): 317-321.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.02.317

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I2/317

References 25

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68:394-424.
[2]	Rapado-González ó, álvarez-Castro A, López-López R, et al. Circulating microRNAs as promising biomarkers in colorectal cancer[J]. Cancers, 2019, 11:898.doi:10.3390/cancers11070898.
[3]	Wang S, Zhang K, Tan S, et al. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies[J]. Mol Cancer, 2021, 20:13.doi:10.1186/s12943-020-01298-z.
[4]	Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic implementation issues and future challenges[J]. Nat Rev Clin Oncol, 2021, 18:297-312.
[5]	Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy[J]. Signal Transduct Target Ther, 2020, 5:145.doi:10.1038/s41392-020-00261-0.
[6]	Rinn JL, Chang HY. Long Noncoding RNAs: molecular modalities to organismal functions[J]. Annu Rev Biochem, 2020, 89:283-308.
[7]	Mehryab F, Rabbani S, Shahhosseini S, et al. Exosomes as a next-generation drug delivery system: an update on drug loading approaches, characterization, and clinical application challenges[J]. Acta Biomater, 2020, 113:42-62.
[8]	Yue B, Yang H, Wang J, et al. Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis[J]. Cell Prolif, 2020, 53:e12857.doi:10.1111/cpr.12857.
[9]	Goodall GJ, Wickramasinghe VO. RNA in cancer[J]. Nat Rev Cancer, 2021, 21:22-36.
[10]	Yao R, Wang Y, Chen L. Cellular functions of long noncoding RNAs[J]. Nature Cell Biology, 2019, 21:542-551.
[11]	Liu ZW, Zhao N, Su YN, et al. Exogenously overex-pressed intronic long noncoding RNAs activate host gene expression by affecting histone modification in arabidopsis[J]. Sci Rep, 2020, 10:3094.doi:10.1038/s41598-020-59697-7.
[12]	Lu C, Wei Y, Wang X, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma[J]. Mol Cancer, 2020, 19:28.doi:10.1186/s12943-020-1137-5.
[13]	Han M, Wang S, Fritah S, et al. Interfering with long non-coding RNA MIR22HG processing inhibits glioblas-toma progression through suppression of Wnt/β-catenin signalling[J]. Brain, 2020, 143:512-530.
[14]	Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J]. Cell Death Dis, 2019, 10:829.doi:10.1138/s41419-019-2077-0.
[15]	Cai H, Yu Y, Ni X, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis[J]. Cell Death Dis, 2020, 11:1032.doi:10.1038/s41419-020-03247-6.
[16]	Luan Y, Li X, Luan Y, et al. Circulating lncRNA UCA1 promotes malignancy of colorectal cancer via the miR-143/MYO6 axis[J]. Mol Ther Nucleic Acids, 2020, 19:790-803.
[17]	Barbagallo C, Brex D, Caponnetto A, et al. LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions[J]. Mol Ther Nucleic Acids, 2018, 12:229-241.
[18]	Yang YN, Zhang R, Du JW, et al. Predictive role of UCA1-containing exosomes in cetuximab-resistant color-ectal cancer[J]. Cancer Cell Int, 2018, 18:164.doi:10.1186/s12935-018-0660-6.
[19]	Yu B, Du Q, Li H, et al. Diagnostic potential of serum exosomal colorectal neoplasia differentially expressed long non-coding RNA (CRNDE-p) and microRNA-217 expression in colorectal carcinoma[J]. Oncotarget, 2017, 8:83745-83753.
[20]	Sun J, Jia H, Bao X, et al. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer[J]. Cell Death Dis, 2021, 12:123.doi:10.1038/s41419-020-03376-y.
[21]	Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19[J]. Theranostics, 2018, 8:3932-3948.
[22]	Oehme F, Krahl S, Gyorffy B, et al. Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer[J]. RNA Biol, 2019, 16:1339-1345.
[23]	Zhao Y, Du T, Du L, et al. Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer[J]. Cell Death Dis, 2019, 10:568.doi:10.1038/s41419-019-1804-x.
[24]	Wang L, Duan W, Yan S, et al. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer[J]. Biomed Pharmacother, 2019, 113:108758.doi:1016/j.biopha.2019.108758.
[25]	Choi JU, Park IK, Lee YK, et al. The biological function and therapeutic potential of exosomes in cancer: exosomes as efficient nanocommunicators for cancer therapy[J]. Int J Mol Sci, 2020, 21:7363.doi:10.3390/ijms21197363.

Research progress of exosome lncRNA in liquid biopsy of colorectal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References 25

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	WANG Fangfang, CAO Huiyuan, WANG Jing, WANG Ning, HUANG Guoliang. Up-regulation of miR-200c-5p inhibits proliferation of human colorectal cancer cell line SW480 [J]. Basic & Clinical Medicine, 2023, 43(2): 241-245.
[2]	JIANG Yu, QIAN Haiyan. Progress in application of mesenchymal stem cells in treatment of acute myocardial infarction [J]. Basic & Clinical Medicine, 2023, 43(1): 21-29.
[3]	SHANG Lipeng, LIU Guoxiang, DING Xiaoyan, LI Bing, ZHAO Chunhua, LI Xiaoxia. Research advances in application of mesenchymal stem cells for aging related diseases [J]. Basic & Clinical Medicine, 2023, 43(1): 38-45.
[4]	YANG Guanglin, REN Lijuan, CHEN Wenjing, XIONG Weijun. LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223 [J]. Basic & Clinical Medicine, 2023, 43(1): 102-109.
[5]	ZHUANG Zhicheng, GUAN Guoxian. Ferroptosis in the treatment of colorectal cancer [J]. Basic & Clinical Medicine, 2023, 43(1): 174-177.
[6]	CHEN Lili,SUN Yonghong,LEI Xiaoyan,WANG Jianjun,CHEN Xingxing,BAO Baixin. Research advances in the treatment of lung diseases based on mesenchymal stem cell exosomes [J]. Basic & Clinical Medicine, 2023, 43(1): 192-195.
[7]	HUANG Hua, ZHOU Long, YAO Di, XU Yi. LncRNA PVT1 alleviates inflammation of airway via regulating miR-214/STAT6 axis in mouse models with asthma [J]. Basic & Clinical Medicine, 2022, 42(9): 1374-1380.
[8]	XIE Si-an, CHEN Yi-yang, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, ZHANG Shu-tian. Effect of PTOV1 expression on prognosis of colorectal cancer patients [J]. Basic & Clinical Medicine, 2022, 42(8): 1176-1181.
[9]	BAI Bing, ZHANG Hai-fang, YANG Qing-liang, QIN Yue, ZHOU Chen-long, SONG Ge, WANG Ying. Down-regulation of lncRNA RHPN1-AS1 inhibits proliferation and migration of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2022, 42(6): 940-944.
[10]	XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin. Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines [J]. Basic & Clinical Medicine, 2022, 42(5): 758-762.
[11]	GUO Jing, LI Ya-jie, MOU Han-shuang. LncRNA FGD5-AS1 reduces ox-LDL-induced damage of HUVECs by targeting miR-106a-5p [J]. Basic & Clinical Medicine, 2022, 42(5): 768-775.
[12]	HE Dan, RUAN Zhong-bao. Extracellular vesicles in the pathogenesis of atrial fibrillation [J]. Basic & Clinical Medicine, 2022, 42(4): 671-674.
[13]	ZHANG Jian, ZHANG Ji-jiong. LncRNA UNC5B-AS1 targeting miR-339-5p regulates the proliferation and apoptosis of human lung adenocarcinoma cell line A549 [J]. Basic & Clinical Medicine, 2022, 42(3): 454-460.
[14]	LIU Ming-sheng, CHEN Wen-chao, CAI Ying-chang. Down-regulation of lncRNA DNM3OS enhances radiotherapy sensitivity of human rectal cancer cell line SW-480 by targeting miR-193a-3p [J]. Basic & Clinical Medicine, 2022, 42(2): 260-267.
[15]	DONG Hui, WANG Ting-ting, MA Xiao-hong, MA Sheng-zong, DING Yong-hui. Screening of differential lncRNAs and expression analysis of lncRNA ZEB2-AS1 in ovarian cancer tissues [J]. Basic & Clinical Medicine, 2022, 42(11): 1675-1680.